Does Philip Rackliffe pay a price per share for the GEHC RSU grant?

No cash price per share is associated with this RSU grant. The Form 4 shows a transaction price of 0.0000 per share, indicating a compensation-related award rather than an open-market stock purchase.

GE HealthCare (GEHC) grants 16,458 RSUs to AIS CEO Philip Rackliffe

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

GE HealthCare Technologies Inc. reported that Philip Rackliffe, CEO of AIS, received a grant of 16,458 restricted stock units tied to its common stock. Each unit entitles him to one share at settlement. Half of the units are scheduled to vest on May 15, 2028, and the remaining half on May 15, 2029.

Following this compensation-related award, Rackliffe directly holds 43,187 shares of GE HealthCare common stock. The grant carries no cash exercise price and represents long-term equity-based compensation rather than an open-market stock purchase.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Rackliffe Philip

Role CEO, AIS

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, par value $0.01 per share	16,458	$0.00	--

Holdings After Transaction: Common Stock, par value $0.01 per share — 43,187 shares (Direct, null)

Footnotes (1)

Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on May 15, 2028, and 50% will vest on May 15, 2029. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

Key Figures

RSU grant size: 16,458 units Post-award holdings: 43,187 shares Vesting tranche 1: 50% of 16,458 units +2 more

5 metrics

RSU grant size 16,458 units Restricted stock units awarded to Philip Rackliffe

Post-award holdings 43,187 shares Total GE HealthCare common shares held directly after grant

Vesting tranche 1 50% of 16,458 units Scheduled to vest on May 15, 2028

Vesting tranche 2 50% of 16,458 units Scheduled to vest on May 15, 2029

Transaction price $0.0000 per share Indicates compensation award, not open-market purchase

Key Terms

restricted stock units, vest, settlement

3 terms

restricted stock units financial

"Award of restricted stock units with respect to GE HealthCare Technologies Inc. common stock"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

vest financial

"50% will vest on May 15, 2028, and 50% will vest on May 15, 2029"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

settlement financial

"represents the right to receive, at settlement, one share of GE HealthCare common stock"

Settlement is the process of completing a financial transaction, like buying or selling a stock, by transferring money and ownership between parties. It ensures that both the buyer gets the asset and the seller gets paid, making the deal official. Without settlement, the transaction wouldn't be finalized or legally recognized.

Form 4 Insider Transactions: What Each Field Means →

05/19/2026 - 04:05 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rackliffe Philip

(Last)

(First)

(Middle)

500 W. MONROE STREET

(Street)

CHICAGO

ILLINOIS

60661

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	CEO, AIS

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, par value $0.01 per share	05/15/2026		A		16,458⁽¹⁾⁽²⁾	A	$0	43,187	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on May 15, 2028, and 50% will vest on May 15, 2029.

2. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

Remarks:

	/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact	05/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did GEHC insider Philip Rackliffe receive in this Form 4 filing?

Philip Rackliffe received a grant of 16,458 restricted stock units. Each unit represents the right to receive one share of GE HealthCare common stock at settlement as part of his long-term equity compensation.

How do the restricted stock units granted to GEHC’s Rackliffe vest?

The 16,458 restricted stock units vest in two equal installments. Fifty percent are scheduled to vest on May 15, 2028, and the remaining 50% are scheduled to vest on May 15, 2029, subject to the award’s terms.

How many GEHC shares does Rackliffe hold after this RSU award?

After the reported award, Rackliffe holds 43,187 shares of GE HealthCare common stock directly. This figure reflects his total direct holdings following the 16,458 restricted stock units granted in the reported transaction.

Is the GEHC Form 4 for Rackliffe a buy or a grant of shares?

The transaction is classified as a grant or award acquisition, not an open-market buy. The Form 4 uses transaction code A and describes it as a grant, award, or other acquisition of non-derivative common stock.